Are there any side effects of BPC 157?

BPC 157, while noted for its potential benefits in recovery and tissue repair, does come with concerns regarding side effects, particularly related to tumor growth. Here are key points from Andrew Huberman on the side effects of BPC 157:

1. Angiogenesis and Tumor Risk: BPC 157 promotes angiogenesis (the formation of new blood vessels) by upregulating vascular endothelial growth factor (VEGF). This is in contrast to treatments like Avastin, which inhibit VEGF to reduce tumor size. The concern is that increased levels of VEGF could potentially exacerbate or promote tumor growth, making BPC 157 risky for those worried about cancer 1.

2. Anecdotal Reports vs. Scientific Data: While there are numerous anecdotal claims of rapid recovery from injuries (sometimes even complete tissue transections), the scientific understanding is limited, particularly concerning long-term human effects. The evidence mostly comes from animal studies, which may not fully translate to human outcomes 1.

3. Experimental Use and Monitoring: There is widespread use of BPC 157 without comprehensive understanding of its effects in humans. Users are encouraged to take the minimal effective dose (300-500 micrograms two to three times per week) and to avoid continuous use. Monitoring other health metrics for signs resembling tumor growth is advised 1.

4. Cautions: The potential benefits for recovery should not overshadow the possible risks, including the stimulation of cancer pathways. Users need to be vigilant about their health status when engaging in BPC 157 use 1.

In summary, while BPC 157 may enhance recovery, caution is warranted due to its potential risks, particularly regarding tumor development. Always consult a healthcare provider for personalized advice.